Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 11, Pages e0160421
Publisher
Public Library of Science (PLoS)
Online
2016-11-04
DOI
10.1371/journal.pone.0160421
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved Survival in Liver Transplant Recipients Receiving Prolonged-Release Tacrolimus in the European Liver Transplant Registry
- (2015) R. Adam et al. AMERICAN JOURNAL OF TRANSPLANTATION
- REFINE: A Randomized Trial Comparing Cyclosporine A and Tacrolimus on Fibrosis After Liver Transplantation for Hepatitis C
- (2014) G. Levy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Tacrolimus-Based versus Cyclosporine-Based Immunosuppression in Hepatitis C Virus-Infected Patients after Liver Transplantation: A Meta-Analysis and Systematic Review
- (2014) Zhenmin Liu et al. PLoS One
- Increased Medication Compliance of Liver Transplant Patients Switched From a Twice-Daily to a Once-Daily Tacrolimus-Based Immunosuppressive Regimen
- (2013) M. Eberlin et al. TRANSPLANTATION PROCEEDINGS
- Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…
- (2012) G. J. McKenna et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysms
- (2012) C Elizabeth McCarron et al. BMC Medical Research Methodology
- Development of organ-specific donor risk indices
- (2012) Sanjeev K. Akkina et al. LIVER TRANSPLANTATION
- Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients
- (2012) Dirk R.J. Kuypers et al. TRANSPLANTATION
- Review article: Use of induction therapy in liver transplantation
- (2012) Lionel Rostaing et al. Transplantation Reviews
- Cyclosporine versus Tacrolimus Treated Liver Transplant Recipients with Chronic Hepatitis C: Outcomes Analysis of the UNOS/OPTN Database
- (2011) W. D. Irish et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment
- (2011) Hein A.W. van Onzenoort et al. HYPERTENSION
- Present state of immunosuppressive therapy in liver transplant recipients
- (2011) Russell H. Wiesner et al. LIVER TRANSPLANTATION
- Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation
- (2010) P. Trunečka et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin
- (2010) Evangelos Cholongitas et al. CLINICAL TRANSPLANTATION
- Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
- (2010) Luit Penninga et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Why Most Discovered True Associations Are Inflated
- (2008) John P. A. Ioannidis EPIDEMIOLOGY
- Consistency of Phase III Clinical Trial Abstracts Presented at an Annual Meeting of the American Society of Clinical Oncology Compared With Their Subsequent Full-Text Publications
- (2008) Vincent C. Tam et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients
- (2008) Surendra Shenoy et al. LIVER TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More